Journal Article

Protein Dynamics Associated with Failed and Rescued Learning in the Ts65Dn Mouse Model of Down Syndrome

Tong, Suhong, Block, Aaron, Gardiner, Katheleen J., Costa, Alberto C. S., Stasko, Melissa, Ahmed, Md. Mahiuddin, Dhanasekaran, A. Ranjitha

2015

Overview

Down syndrome (DS) is caused by an extra copy of human chromosome 21 (Hsa21). Although it is the most common genetic cause of intellectual disability (ID), there are, as yet, no effective pharmacotherapies. The Ts65Dn mouse model of DS is trisomic for orthologs of ∼55% of Hsa21 classical protein coding genes. These mice display many features relevant to those seen in DS, including deficits in learning and memory (L/M) tasks requiring a functional hippocampus. Recently, the N-methyl-D-aspartate (NMDA) receptor antagonist, memantine, was shown to rescue performance of the Ts65Dn in several L/M tasks. These studies, however, have not been accompanied by molecular analyses. In previous work, we described changes in protein expression induced in hippocampus and cortex in control mice after exposure to context fear conditioning (CFC), with and without memantine treatment. Here, we extend this analysis to Ts65Dn mice, measuring levels of 85 proteins/protein modifications, including components of MAP kinase and MTOR pathways, and subunits of NMDA receptors, in cortex and hippocampus of Ts65Dn mice after failed learning in CFC and after learning was rescued by memantine. We show that, compared with wild type littermate controls, (i) of the dynamic responses seen in control mice in normal learning, >40% also occur in Ts65Dn in failed learning or are compensated by baseline abnormalities, and thus are considered necessary but not sufficient for successful learning, and (ii) treatment with memantine does not in general normalize the initial protein levels but instead induces direct and indirect responses in approximately half the proteins measured and results in normalization of the endpoint protein levels. Together, these datasets provide a first view of the complexities associated with pharmacological rescue of learning in the Ts65Dn. Extending such studies to additional drugs and mouse models of DS will aid in identifying pharmacotherapies for effective clinical trials.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Abnormalities / Analysis / Animal models / Animals / Aspartate / Brain / Chromosome 21 / Clinical trials / Disease Models, Animal / Down syndrome / Down Syndrome - drug therapy / Down Syndrome - genetics / Down Syndrome - metabolism / Down's syndrome / Drug dosages / Drug therapy / Drugs / Fear conditioning / Genomes / Genomics / Glutamic acid receptors (ionotropic) / Hippocampus / Intellectual disabilities / Learning / Learning - drug effects / MAP kinase / Medical research / Memantine / Memantine - pharmacology / Memory / Memory tasks / Mice / N-methyl-D-aspartate / N-Methyl-D-aspartic acid receptors / Pediatrics / Pharmacology / Protein Subunits - metabolism / Proteins / Proteome / Proteomics - methods / Receptors / Receptors, N-Methyl-D-Aspartate - chemistry / Receptors, N-Methyl-D-Aspartate - metabolism / Rodents / TOR protein